ID   TsuGK27
AC   CVCL_M134
SY   TSUGK27; TSUGK-27
DR   cancercelllines; CVCL_M134
DR   Wikidata; Q54973175
RX   PubMed=9365544;
CC   Problematic cell line: Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4014 ! TSU-Pr1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
RX   PubMed=9365544; DOI=10.1002/(SICI)1097-0045(19971101)33:3<166::AID-PROS4>3.0.CO;2-H;
RA   Gschwend, Jurgen Erich
RA   Fair, William R.
RA   Powell, C. Thomas
RT   "Evaluation of the tetracycline-repressible transactivator system for
RT   inducible gene expression in human prostate cancer cell lines.";
RL   Prostate 33:166-176(1997).
//